Document is current
Any future updates will be listed below
-
Authors
Bannoura, Sahar F.
Uddin, Md. Hafiz
Nagasaka, Misako
Fazili, Farzeen
Al-Hallak, Mohammed Najeeb
Philip, Philip A.
El-Rayes, Bassel
Azmi, Asfar S.
- License Information
-
More Information
Article History
Received: 6 August 2021
Accepted: 27 August 2021
First Online: 9 September 2021
Declarations
:
: ASA received funding from Karyopharm Therapeutics, Janssen, Rhizen, and EISAI. ASA serves as a consultant for GLG and Guidepoint.
